The recent challenges in global chains have highlighted the value of securing critical medications like Ivermectin. Dependence on overseas vendors exposes nations to considerable vulnerabilities, including transportation delays, price fluctuations, and even political concerns. Shifting towards domestic procurement of Ivermectin offers a multitude o